drugset / Trial / NCT02797587
Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Phase 2/3
Completed
400 enrolled
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized controlled trial (RCT) to compare the effects of varenicline, cytisine, and nicotine replacement therapy (NRT) to reduce: 1) alcohol use and craving, 2) smoking; and 3) inflammation and risk for coronary heart disease (CHD) and mortality among 400 HIV-infected Russians, with heavy alcohol consumption and tobacco use.
Timeline
- Start
- 2017-07-19
- Primary completion
- 2020-04-30
- Completion
- 2020-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cytisinicline | Small molecule | 3 mg | — |
| Comparator | Cytisinicline | Small molecule | 9 mg | — |
| Comparator | Varenicline | Small molecule | 1 mg | — |